Published in Int J Endocrinol on May 12, 2014
AACE response to a candid discussion of obesity. Am J Med (2015) 0.75
Determinants of Secondary Hyperparathyroidism in Bariatric Patients after Roux-en-Y Gastric Bypass or Sleeve Gastrectomy: A Pilot Study. Int J Endocrinol (2015) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr (1998) 8.97
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell (1999) 7.56
Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med (2010) 6.63
Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol (1988) 6.34
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care (2004) 5.34
Medical consequences of obesity. J Clin Endocrinol Metab (2004) 5.30
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
AACE comprehensive diabetes management algorithm 2013. Endocr Pract (2013) 4.88
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse (2001) 4.03
Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells (2007) 3.99
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism (2001) 3.25
Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) (2010) 3.17
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res (2007) 2.25
The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science (2013) 2.22
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther (2008) 2.17
Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) (2011) 2.09
A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab (2011) 1.98
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther (2008) 1.95
Weight control in the physician's office. Arch Intern Med (2001) 1.94
The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res (1999) 1.70
Treatment with antipsychotics and the risk of diabetes in clinical practice. Br J Psychiatry (2010) 1.67
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) (2012) 1.66
Withdrawal of sibutramine in Europe. BMJ (2010) 1.64
Basic science review on adipose tissue for clinicians. Plast Reconstr Surg (2010) 1.62
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis (2013) 1.60
The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol (2011) 1.59
Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J Neurosci (2013) 1.48
Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. Pharmacol Ther (2009) 1.48
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res (2003) 1.47
Position of the American Dietetic Association: integration of medical nutrition therapy and pharmacotherapy. J Am Diet Assoc (2003) 1.47
Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med (1985) 1.46
The non-regulation of food intake in humans: hope for reversing the epidemic of obesity. Physiol Behav (2005) 1.43
The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle (2012) 1.35
Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol (2013) 1.31
Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev (2012) 1.28
Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) (2010) 1.23
Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol (2012) 1.16
Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans. Int J Obes (Lond) (2007) 1.14
Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol (2008) 1.12
The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc (2012) 1.11
Dual-process action of exercise on appetite control: increase in orexigenic drive but improvement in meal-induced satiety. Am J Clin Nutr (2009) 1.10
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obes Rev (2009) 1.10
A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine. Arch Int Pharmacodyn Ther (1969) 1.06
Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol (2005) 1.05
Position of the American Dietetic Association: weight management. J Am Diet Assoc (2002) 1.05
Orlistat: a review of its use in the management of obesity. Drugs (2006) 1.04
Comparison of visceral fat and liver fat as risk factors of metabolic syndrome. J Korean Med Sci (2012) 1.04
Validation of DXA body composition estimates in obese men and women. Obesity (Silver Spring) (2009) 1.03
Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Expert Rev Cardiovasc Ther (2010) 1.01
Hedonic hunger and binge eating among women with eating disorders. Int J Eat Disord (2013) 1.00
Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis (1982) 0.99
Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. J Clin Endocrinol Metab (2010) 0.98
Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res (2011) 0.97
Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office. Am J Cardiol (2007) 0.97
Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything. Expert Rev Cardiovasc Ther (2005) 0.97
Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. PLoS One (2012) 0.96
Inflammation and cardiovascular disease: is abdominal obesity the missing link? Int J Obes Relat Metab Disord (2003) 0.96
Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy? Metabolism (1999) 0.95
Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs. Obes Rev (2013) 0.95
Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism (2011) 0.95
Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? J Am Coll Cardiol (2011) 0.94
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone. Curr Atheroscler Rep (2006) 0.94
Abdominal obesity and cardiovascular disease risk factors within body mass index categories. Health Rep (2012) 0.93
Withdrawal of sibutramine leaves European doctors with just one obesity drug. BMJ (2010) 0.92
Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity. Med Hypotheses (2010) 0.91
Adiposopathy: role of adipocyte factors in a new paradigm. Expert Rev Cardiovasc Ther (2005) 0.91
A multidisciplinary approach to obesity management: the physician's role and team care alternatives. J Am Diet Assoc (1998) 0.91
Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol (2005) 0.90
Increased waist circumference is associated with an increased prevalence of mood disorders and depressive symptoms in obese women. Eat Weight Disord (2007) 0.90
Visceral fat area, waist circumference and metabolic risk factors in abdominally obese Chinese adults. Biomed Environ Sci (2012) 0.90
Evaluation of the obese patient. Practical considerations. Med Clin North Am (2000) 0.89
A systematic review of the clinical effectiveness of orlistat used for the management of obesity. Obes Rev (2004) 0.89
Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract (2008) 0.88
Intensive nutrition counseling enhances outcomes of National Cholesterol Education Program dietary therapy. J Am Diet Assoc (1996) 0.88
Obstructive sleep apnea and obesity. Otolaryngol Clin North Am (1990) 0.87
Evidence that the nucleus accumbens shell, ventral pallidum, and lateral hypothalamus are components of a lateralized feeding circuit. Behav Brain Res (2011) 0.87
BMI Correlates Better to Visceral Fat and Insulin Sensitivity Than BAI. Obesity (Silver Spring) (2012) 0.87
A study of abrupt phentermine cessation in patients in a weight management program. Am J Ther (2011) 0.86
Dietitian-coached management in combination with annual endocrinologist follow up improves global metabolic and cardiovascular health in diabetic participants after 24 months. Appl Physiol Nutr Metab (2012) 0.86
Psychological predictors of adiposity: systematic review of longitudinal studies. Int J Pediatr Obes (2011) 0.85
Circadian integration of sleep-wake and feeding requires NPY receptor-expressing neurons in the mediobasal hypothalamus. Am J Physiol Regul Integr Comp Physiol (2011) 0.85
Major depression, borderline personality disorder, and visceral fat content in women. Eur Arch Psychiatry Clin Neurosci (2011) 0.85
Withdrawal of Rimonabant--walking the tightrope of 21st century pharmaceutical regulation? Curr Drug Saf (2009) 0.84
Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J (2011) 0.83
Neural integration of reward, arousal, and feeding: recruitment of VTA, lateral hypothalamus, and ventral striatal neurons. IUBMB Life (2011) 0.83
Epidemic trends of obesity with impact on metabolism and digestive diseases. Dig Dis (2012) 0.83
Obesity as a disease state: a new paradigm for diagnosis and treatment. Clin Cornerstone (2009) 0.82
Relationship between Obesity, Depression, and Disability in Middle-Aged Women. Obes Res Clin Pract (2012) 0.82
Lighting up the hypothalamus: coordinated control of feeding behavior. Nat Neurosci (2011) 0.81
Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients. Nutr Metab Cardiovasc Dis (2012) 0.81